# An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery

> **NCT00122018** · PHASE2 · COMPLETED · sponsor: **Linda F. Barr, M.D.** · enrollment: 80 (—)

## Conditions studied

- Kidney Failure, Acute
- Kidney Failure, Chronic
- Cardiac Surgical Procedures

## Interventions

- **DRUG:** N-acetylcysteine
- **DRUG:** fenoldopam

## Key facts

- **NCT ID:** NCT00122018
- **Lead sponsor:** Linda F. Barr, M.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 80 (—)
- **Last updated:** 2014-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00122018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00122018, "An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00122018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*